Trial intelligence / Profile preview

Acetazolamide for OSA at Altitude

NCT00714740Phase 4Completed

Sponsor
University of Zurich
Start
Jun 2008
Primary completion
Dec 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in obstructive sleep apnea syndrome (OSAS) comparing Acetazolamide with Placebo (2 arms). Primary endpoints: Apnea-Hypopnea Index, Sleep Structure and 3 more. Started Jun 2008; status: completed.

02

Drugs

acetazolamide
03

Conditions

obstructive sleep apnea syndrome (OSAS)

Beyond the preview

Go deeper on NCT00714740.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00714740.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call